Emcure Pharmaceuticals, founded by Namita Thapar's father, is set to raise around Rs. 1,952 crore through its IPO. Thapar, the Executive Director, will sell a 3.5% stake in the company, potentially making Rs. 126 crore. With key therapeutic areas and a strong global presence, Emcure's debut on the market comes at an opportune time for India's pharma sector.
Emcure Pharmaceuticals: A Rising Star in the Pharmaceutical Industry
Emcure Pharmaceuticals, a leading Indian pharmaceutical company, is poised to make its debut on the stock market through an initial public offering (IPO). The company, founded by Namita Thapar's father, Satish Mehta, plans to raise around Rs. 1,952 crore through the IPO.
Background
Emcure Pharmaceuticals was established in 1981 in Pune, India. The company has a strong presence in key therapeutic areas such as cardiology, diabetes, and oncology. It has a global footprint, with operations in over 100 countries.
Namita Thapar, the Executive Director of Emcure Pharmaceuticals, is a renowned businesswoman and angel investor. She is known for her participation as a judge on the popular Indian television show "Shark Tank India."
IPO Details
Emcure Pharmaceuticals is set to sell shares worth Rs. 1,952 crore through its IPO. The price band for the IPO has been set at Rs. 419-422 per share. The issue will open for subscription on March 18, 2023, and close on March 20, 2023.
Thapar, who owns a 3.5% stake in Emcure Pharmaceuticals, is expected to sell a portion of her shares in the IPO. This could potentially net her around Rs. 126 crore.
Opportune Time for Indian Pharma Sector
The IPO of Emcure Pharmaceuticals comes at an opportune time for the Indian pharmaceutical sector. The sector is expected to grow at a compounded annual growth rate (CAGR) of around 10% over the next five years. Factors such as increasing healthcare spending, government initiatives, and a growing aging population are driving this growth.
Top 5 FAQs
1. When is Emcure Pharmaceuticals' IPO opening?
The IPO will open for subscription on March 18, 2023, and close on March 20, 2023.
2. What is the price band for the IPO?
The price band for the IPO is Rs. 419-422 per share.
3. How much is Namita Thapar expected to sell in the IPO?
Thapar, who owns a 3.5% stake in Emcure Pharmaceuticals, is expected to sell a portion of her shares in the IPO. This could potentially net her around Rs. 126 crore.
4. Which are Emcure Pharmaceuticals' key therapeutic areas?
Emcure Pharmaceuticals' key therapeutic areas include cardiology, diabetes, and oncology.
5. What is the company's global footprint?
Emcure Pharmaceuticals has a global footprint, with operations in over 100 countries.
BTTV, a leading market news channel, introduces a new show called 'Daily Calls' aimed at providing viewers with expert insights and guidance on navigating the market. With access to live sessions featuring experienced analysts, the show aims to assist viewers in making informed investment decisions and building a strong portfolio. Don't miss out on this valuable opportunity to gain clarity and understanding in today's uncertain market.
Adani Group is under scrutiny for alleged violations of disclosure norms concerning a US bribery case and the subsequent cancellation of major deals by Kenya. While the conglomerate has denied any involvement in the case, stock exchanges have sought explanations and experts believe that the Securities and Exchange Board of India (SEBI) may launch an investigation. The allegations, which include a criminal indictment and a civil complaint, could have significant consequences for Adani Group's reputation and access to international markets.
Outlandish, an e-commerce startup, is opening a new brick-and-mortar store in Santa Monica's 3rd Street Promenade, featuring a first floor of branded stalls and a second floor for shopping. The store aims to mix live online selling with in-person retail, as visitors can watch influencers and sellers on livestreams and even join in themselves. The concept taps into the growing trend of live shopping in the US, with TikTok itself actively promoting and hosting events centered around live selling. This move by Outlandish is in line with TikTok's efforts to recreate the success of its Chinese sister app, Douyin, which drives billions in annual product sales.
The highly volatile Mad cryptocurrency has seen a massive surge of 67% in the last 24 hours, trading at $0.00006226 as of 02:49 a.m. EST. This sudden spike in price, along with a heavy overbought RSI level of 86, signals a potential correction or pullback in the near future. However, the Mad price has managed to break above both the 50-day and 200-day SMAs, indicating a strong and sustained bullish trend. The ADX value above 60 also confirms the strength of this rally. Stay updated on this exciting development by joining our Telegram channel.
In a note released on Friday, JPMorgan addressed concerns over potential credit risk for Indian banks heavily exposed to the Adani Group, following the recent indictment of its billionaire founder, Gautam Adani, in the US. While the charges have sparked a drop in shares of state-owned banks, JPMorgan analysts have deemed the banks' exposure "manageable," with their assessment showing a low risk of default from the Adani Group. However, global and local banks are expected to take a cautious approach in providing any new funding to the conglomerate, with potential for higher interest rates due to heightened risks.
In a state of the nation address, Kenya's President announced the cancellation of major deals with Indian tycoon Gautam Adani, including an airport expansion project and power transmission lines. This decision was made in light of U.S. bribery and fraud indictments against Adani, who has been charged with securities fraud and conspiracy. The controversial deals had faced backlash from Kenyan protesters and airport workers concerned about potential job losses. Despite claims from Kenya's Energy Minister that no corruption was involved on their part, the country has now severed ties with Adani's conglomerate.
X's new terms of service, which allow the company to use user data and hold users accountable for overusing the platform, are prompting long-time users, including celebrities like Gabrielle Union, to leave the popular microblogging platform. In response, many users are turning to Bluesky, a microblogging startup, with its U.S. mobile app downloads increasing by an estimated 651% since the start of November. Despite X and Meta's larger user bases, Bluesky's growth suggests many users are looking for alternatives to X's new terms.
Zomato’s new “Food Rescue” feature caught the attention of Bengaluru resident Bhanu who offered practical and thoughtful suggestions to CEO Deepinder Goyal. Impressed by his insights, Goyal extended an unexpected job offer to Bhanu, a product manager working for a startup. This positive exchange highlights the importance of hiring talented individuals who offer practical solutions to enhance a company’s operations. Zomato, known for handling over 4,00,000 cancelled orders per month, aims to prevent food wastage with their new feature, which offers discounted meals to customers within a 3km radius of a delivery partner with a cancelled order.
Zerodha co-founder and CEO Nithin Kamath shared a humorous mock obituary for Bank Nifty Weekly contracts on social media. The post, created by one of his old trader friends, announced the "passing" of Bank Nifty Weekly and mentioned its struggles with regulation. The post has since gone viral, with many traders reminiscing about their experiences with this contract.
The Zee Business research team has compiled a list of 20 stocks for investors and traders to track on November 22, 2024. Analysts Kushal Gupta and Ashish Chaturvedi have highlighted their top picks, including buying Orchid Pharma and SJVN shares for immediate profits, and investing in MRF, Radico Khaitan and Afcons Infrastructure for long-term gains. Technical and fundamental picks are also included, making this Traders' Diary a must-read for all stock market enthusiasts.